Frequently Asked Questions
The market is segmented based on , By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), End User (Hospitals, Oncology Institutes, Biotechnological Companies, Clinical Research Laboratories) – Industry Trends and Forecast to 2029.
.
The Global Cancer Gene Therapy Market size was valued at USD 1.73 USD Billion in 2021.
The Global Cancer Gene Therapy Market is projected to grow at a CAGR of 9.7% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
